Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
about
The Prodrug Approach: A Successful Tool for Improving Drug SolubilityHeparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesisCooperative roles of SDF-1α and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic modelPlasmodium falciparum proteins involved in cytoadherence of infected erythrocytes to chemokine CX3CL1Leading and trailing cells cooperate in collective migration of the zebrafish posterior lateral line primordiumCXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.The chemokine CXCL12 is essential for the clearance of the filaria Litomosoides sigmodontis in resistant miceChemokine cooperativity is caused by competitive glycosaminoglycan binding.Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine.Dietary chalcones with chemopreventive and chemotherapeutic potential.Glycosaminoglycan analogs as a novel anti-inflammatory strategyAn antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in miceFunctional diversity of SDF-1 splicing variants.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Genetics on a WHIM.Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease.Glycosaminoglycan silencing by engineered CXCL12 variants.Chalcone Derivatives: Promising Starting Points for Drug Design.Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo.Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.Acute Asthma Models to Ovalbumin in the Mouse.A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate.Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine functionFluorescent ligands for G protein-coupled receptors: illuminating receptor-ligand interactions for drug discovery.Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells.Critical involvement of atypical chemokine receptor CXCR7 in allergic airway inflammation.Performing Bronchoalveolar Lavage in the Mouse.CXCR7 Targeting and Its Major Disease Relevance.A Fast, Easy, and Customizable Eight-Color Flow Cytometric Method for Analysis of the Cellular Content of Bronchoalveolar Lavage Fluid in the Mouse
P2860
Q26771271-2C018B3B-32FE-4C1A-88B1-90D17F56B245Q26852845-E6CF2ABB-F259-44CF-83D0-11A03A25A8ACQ27311460-9D53E81D-62FF-4A4F-BCD2-39B74645C8BAQ30042320-56093533-D49C-4386-A6AA-8EBF1059E042Q30592593-2836F3A5-856E-4616-90E6-B3B50EFCCC88Q33677057-81C77BF5-167D-46D8-A212-AEF069ECE5A3Q34236931-7710B566-16B1-4250-B5C0-6E62EBB9B410Q34344569-93502D6D-1DD5-4C9A-8412-59A128B915CCQ34569177-ACBC08E0-51A4-4629-90E5-44EDF09D2AE9Q34631525-312F23C4-18DF-4D67-9D7A-EBE09A0DEFD6Q34975832-5C2F9BAF-1936-4FA2-AF6D-0FD7FB4966B1Q36321143-DE84BAFB-B7A4-4820-9C1E-98B6F8942D38Q36796828-938FF18F-D777-49FE-9856-60935483A0D7Q37415245-064829BD-E322-441B-B42B-2058F4D6FF0CQ37432097-BBE09376-D6F1-4F02-87B6-0E954DD1D5AFQ37653020-5392572B-5DD2-454E-91FA-CEC616803BEDQ37684176-9A5E6D41-5CB3-4016-A3DF-EBECAB94F30BQ37866794-9A6C353C-43A9-43C2-9C5D-9BF8C8BD0C81Q38079237-ECE5CE59-0D50-4698-B2DA-A7C6BFC016F8Q38841772-0D00C9BD-09E5-4181-BE51-526C5C0EA8DEQ39027317-0D331F79-5EC8-482C-B0BD-1F6F5DC0E7F7Q39644174-051F7E71-80DA-4768-8B1E-9767084641DFQ39736612-7319D077-A1D0-453F-84CD-4548FF588B71Q40207930-8A76353C-5EB8-4BDF-9C10-68E45D6E969DQ40841697-3371773F-A32D-4579-90B4-B7DAF3FA1569Q41201376-98AAFD99-C94E-47FD-B812-1B3CEE563B96Q41843794-F2EB9686-0910-4C1C-B5F6-22F1B2246D9CQ41861205-CCC5B191-D1E4-4377-872C-439F291B9D0BQ44404761-4DE173B5-C405-4B02-A006-28CAC2C8C629Q44877639-52C2798A-A900-4390-B2A4-24540153D614Q48103055-EBA07998-6BA0-480A-9809-BF5D0045451EQ54331613-5F48F278-F7C3-4134-9611-19F8310FD19AQ55513575-A90FFFBB-97B9-4CD6-B9CE-71374861F804Q57314985-DC8EB480-C726-4BE7-B9F5-603561F41650
P2860
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@ast
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@en
type
label
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@ast
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@en
prefLabel
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@ast
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@en
P2093
P2860
P50
P356
P1476
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
@en
P2093
Bernard Lagane
Bruno Didier
Christel Franchet
Fernando Arenzana-Seisdedos
François Rohmer
Françoise Baleux
Françoise Pons
Jacques Haiech
Jean-Luc Galzi
Ken Y C Chow
P2860
P304
23189-23199
P356
10.1074/JBC.M803947200
P407
P577
2008-06-13T00:00:00Z